Toggle Nav
Close
  • Menu
  • Setting

Anti-NRP1/VEGF165R/CD304 Antibody (Vesencumab)

Catalog No.
F1368
Anti-NRP1/VEGF165R/CD304 Antibody (Vesencumab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Vesencumab (MNRP-1685A) is aNeuropilin-1 (NRP-1) Vesencumab is an antibody against IG1. Vesencumab binds to NRP-1 and prevents NRP-1 from coupling to VEGFR-2. Vesencumab has anti-angiogenic and anti-tumor activity. Vesencumab can be used in the study of metastatic solid tumors, including ovarian cancer.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.22 kDa

Shipping

Dry ice

Cas No.

1205533-60-3

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

M 1685A, R-7347, RG7347

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

O14786

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human NRP1 His at 2 ug/mL can bind Anti-NRP1/VEGF165R/CD304 Antibody (Vesencumab)

Target

NRP1 / VEGF165R / CD304

Note

Please avoid freeze-thaw cycles.